Resolution of Fenfluramine-associated pulmonary arterial hypertension in Lennox-Gastaut syndrome: A case report and literature review
Fenfluramine is a medication originally approved for weight loss before being withdrawn for an association with the development of pulmonary arterial hypertension (PAH) and cardiac valvulopathy. Interest in fenfluramine at lower doses has re-emerged for treatment of drug-resistant epilepsy (DRE). He...
Saved in:
| Main Authors: | Rebecca Strafella, Richard Wang, Marissa Petchpradub, Ariel Sacknovitz, Patricia E. McGoldrick, Steven M. Wolf |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-01-01
|
| Series: | Epilepsy & Behavior Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S258998642400087X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the Burden of Lennox−Gastaut Syndrome: Implications for Patients, Caregivers, and Society in High and Low Resource Settings: A Narrative Review
by: Marina Ramzy Mourid, et al.
Published: (2024-12-01) -
Bilateral pulvinar responsive neurostimulation for bilateral multifocal posteriorly dominant drug resistant epilepsy
by: Richard Wang, et al.
Published: (2024-12-01) -
Development of cohort definitions and algorithms to identify patients with Lennox-Gastaut syndrome or Dravet syndrome from real-world administrative healthcare databases
by: Drishti Shah, et al.
Published: (2025-02-01) -
Perampanel reduces seizure frequency in patients with developmental and epileptic encephalopathy for a long term
by: Hirokazu Yamagishi, et al.
Published: (2024-12-01) -
Refining management strategies for Lennox–Gastaut syndrome: Updated algorithms and practical approaches
by: Stéphane Auvin, et al.
Published: (2025-02-01)